Table 2 Biomarker plasma concentrations

SP-D [ng/mL] - Median (IQR)

0.068

0.001

0.014

CABG

4.15 (2.88-7.99)

4.71 (2.83-7.92)

4.59 (3.00-13.36)

6.20 (3.19-13.44)

8.96 (7.32-14.12)

8.71 (5.25-13.91)

5.69 (2.99-11.46)

OPCAB

4.39 (1.97-8.08)

3.51 (2.67-6.95)

4.27 (2.61-6.75)

4.14 (2.48-5.26)

4.91 (2.07-10.72)

5.08 (3.43-7.39)

3.99 (0.59-6.72)

CC16 [ng/mL] - Median (IQR)

0.988

<0.001

0.068

CABG

5.41 (4.38-9.21)

6.45 (4.25-9.45)

8.15 (5.88-13.56)

10.36 (6.18-16.79)

10.47 (6.50-14.34)

7.95 (4.33-13.23)

4.66 (3.92-9.18)

OPCAB

5.14 (5.59-15.06)

7.95 (4.79-11.09)

10.61 (7.62-14.02)

8.33 (6.22-11.64)

8.34 (5.64-13.42)

7.15 (4.57-14.50)

3.92 (2.28-7.43)

Elastase [ μg/mL] - Median (IQR)

0.002

<0.001

<0.001

CABG

2.16 (1.63-3.19)

1.87 (1.61-3.46)

2.68 (2.03-3.13)

4.09 (2.32-4.95)

29.1 (14.3-2.24)

37.7 (14.0-55.9)

16.7 (7.63-24.6)

OPCAB

1.43 (1.17-2.85)

2.17 (1.61-3.46)

2.12 (1.25-2.86)

2.89 (2.12-3.47)

4.02 (2.24-4.90)

5.13 (3.13-6.95)

12.9 (7.97-20.9)

MPO [ng/mL] - Median (IQR)

0.025

<0.001

<0.001

CABG

37 (28–45)

28 (23–48)

441 (334–527)

507 (401–571)

191 (133–310)

134 (80–170)

52 (45–58)

OPCAB

41 (32–50)

38 (32–45)

367 (314–386)

360 (319–388)

172 (101–304)

109 (64–148)

59 (48–80)